Patient awareness campaigns and digital health platforms are increasing treatment-seeking behavior among urban populations with obesity concerns
On the other hand, gastric emptying is not considerably impacted by glucose-dependent insulinotropic polypeptide (GIP), emphasizing the distinct functions of these incretins in GI function ( A study examined the potential advantages and disadvantages of using GLP-1RAs to help obese but non-diabetic patients lose weight
Obesity is becoming a bigger problem in the Nordics too, although its not yet as serious as it is in the U.S., says Holst
Its just a lot of the same hard work. Even if you stay on GLP-1s, you will likely have to adjust your maintenance dosage because your body will adapt over time and those primal, caveman instincts will creep back in
Some patients tolerate alternative agents, while others may experience similar reactions
When that food sits too long, it becomes a playground for gut bacteria